12134 Federal Register / Vol. 74, No. 54 / Monday, March 23, 2009 / Notices 

such as their age and time in the mining 

industry. Additional data will then be 

collected at 1, 3, and 6 months after the 

study commences. The mine workers 

will be asked to provide their feedback 

regarding factors such as body part 

discomfort, usability, durability, and 

ease of movement. 

There will be no cost to the 

respondents. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Section Foreman (pilot mine) .......................................................................... 1 1 10/60 0 .5 

Mine Workers (pilot mine—baseline) ............................................................... 9 1 20/60 3 

Mine Workers (pilot mine—one month) ........................................................... 9 1 30/60 4 .5 

Mine Workers (pilot mine—focus group) ......................................................... 9 1 1 9 

Section Foreman (full study) ............................................................................ 6 12 10/60 12 

Mine Workers (full study—baseline) ................................................................ 54 1 20/60 18 

Mine Workers (full study—1, 3, and 6 months for control and prototypes) .... 54 6 25/60 135 

Total .......................................................................................................... ........................ ........................ ........................ 182 

Dated: March 11, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–6214 Filed 3–20–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): CDC Grants for 

Public Health Research Dissertation, 

Panel F, Funding Opportunity 

Announcement (FOA) PAR07–231 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 2 p.m.–5 p.m., May 12, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘CDC Grants for Public Health 

Research Dissertation, Panel F, FOA PAR07– 

231.’’ 

For Further Information Contact: Susan B. 

Stanton, D.D.S., Scientific Review Officer, 

Office of the Director, Office of the Chief 

Science Officer, CDC, 1600 Clifton Road, NE., 

Mailstop D74, Atlanta, GA 30333, Telephone: 

(404) 639–4640. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 16, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–6216 Filed 3–20–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Acceptability, 

Feasibility and Validity of Genital SelfSampling for HPV Among Men, PEP 

2009–R–01 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 10 a.m.–12 p.m., May 18, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Acceptability, Feasibility and 

Validity of Genital Self-Sampling for HPV 

Among Men, PEP 2009–R–01.’’ 

Contact Person for More Information: 

Linda Shelton, Public Health Analyst, 

Coordinating Center for Health and 

Information Service, Office of the Director, 

CDC, 1600 Clifton Road, NE., Mailstop E21, 

Atlanta, GA 30333, Telephone (404) 498– 

1194. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 6, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–6220 Filed 3–20–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group 

(NCIPC, IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following meeting: 

Times and Date: 1 p.m.–1:30 p.m., April 

30, 2009 (Open). 1:30 p.m.–6 p.m., April 30, 

2009 (Closed). 

Place: Teleconference, Toll Free: 888–793– 

2154, Participant Passcode: 4424802, CDC, 

Chamblee Campus, Building 106, 4770 

Buford Highway, Atlanta, GA 30341. 

Status: Portions of the meetings will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5, U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Section 

10(d) of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 


dwashington3 on PROD1PC60 with NOTICES